Your browser doesn't support javascript.
loading
Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies.
Shah, Manish A; Udrea, Anghel Adrian; Bondarenko, Igor; Mansoor, Was; Sánchez, Raquel Guardeño; Sarosiek, Tomasz; Bozzarelli, Silvia; Schenker, Michael; Gomez-Martin, Carlos; Morgan, Carys; Özgüroglu, Mustafa; Pikiel, Joanna; Kalofonos, Haralabos P; Wojcik, Elzbieta; Buchler, Tomas; Swinson, Daniel; Cicin, Irfan; Joseph, Mano; Vynnychenko, Ihor; Luft, Alexander Valerievich; Enzinger, Peter C; Salek, Tomas; Papandreou, Christos; Tournigand, Christophe; Maiello, Evaristo; Wei, Ran; Ferry, David; Gao, Ling; Oliveira, Joana M; Ajani, Jaffer A.
Afiliación
  • Shah MA; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medical College, New York, NY 10021, USA.
  • Udrea AA; Cancer Center, Medisprof SRL, 400641 Cluj-Napoca, Romania.
  • Bondarenko I; Department of Oncology, Dnipropetrovsk Medical Academy, 49044 Dnipropetrovsk, Ukraine.
  • Mansoor W; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK.
  • Sánchez RG; Department of Medical Oncology, Catalan Institute of Oncology (ICO) Girona Hospital Dr Josep Trueta, 17007 Girona, Spain.
  • Sarosiek T; Department of Clinical Oncology and Oncological Surgery, LUXMED Onkologia, 04125 Warszawa, Poland.
  • Bozzarelli S; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, 20089 Milan, Italy.
  • Schenker M; Centrul de Oncologie Sf. Nectarie SRL, 200542 Craiova, Romania.
  • Gomez-Martin C; Department of Medical Oncology, University of Medicine and Pharmacy Craiova, 200342 Craiova, Romania.
  • Morgan C; Medical Oncology Department, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
  • Özgüroglu M; Department of Clinical Oncology, Velindre Cancer Centre, Cardiff CF14 2TL, UK.
  • Pikiel J; Medical Oncology, Istanbul University, Cerrahpasa, Fatih, Istanbul 34098, Turkey.
  • Kalofonos HP; Department of Oncology, Copernicus Podmiot Leczniczy, 80-803 Gdansk, Poland.
  • Wojcik E; Department of Oncology, University General Hospital of Patras Rion, 26504 Patras, Greece.
  • Buchler T; NZOZ Centrum Medyczne HCP, 62-030 Lubon, Poland.
  • Swinson D; Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, 14059 Prague, Czech Republic.
  • Cicin I; Institute of Oncology, St James's University Hospital, Leeds LS9 7TF, UK.
  • Joseph M; Medical Oncology, Trakya University, Edirne 22030, Turkey.
  • Vynnychenko I; Deanesly Centre, New Cross Hospital, Wolverhamptom WV10 0QP, UK.
  • Luft AV; Sumy Regional Oncology Center, Sumy State University, 40000 Sumy, Ukraine.
  • Enzinger PC; Department of Oncology No 1 (Thoracic Surgery), Leningrad Regional Clinical Hospital, 194291 St. Petersburg, Russia.
  • Salek T; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
  • Papandreou C; Department of Clinical Oncology, Narodny Onkologicky Ustav, 83310 Bratislava, Slovakia.
  • Tournigand C; Department of Medical Oncology, Faculty of Medicine, University of Thessaly, Biopolis, 41223 Larissa, Greece.
  • Maiello E; Department of Medical Oncology, Henri Mondor et Albert Chenevier Teaching Hospital, Assistance Publique-Hôpitaux de Paris, University of Paris-Est Creteil, 94000 Créteil, France.
  • Wei R; Oncology Unit, Foundation Casa Sollievo della Sofferenza IRCCS, Viale Cappuccini 1, 71013 San Giovanni Rotondo, Italy.
  • Ferry D; Eli Lilly and Company, Indianapolis, IN 46225, USA.
  • Gao L; Eli Lilly and Company, New York, NY 10016, USA.
  • Oliveira JM; Eli Lilly and Company, New York, NY 10016, USA.
  • Ajani JA; Eli Lilly and Company, New York, NY 10016, USA.
Cancers (Basel) ; 14(5)2022 Feb 24.
Article en En | MEDLINE | ID: mdl-35267477
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Systematic_reviews Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Systematic_reviews Idioma: En Revista: Cancers (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos